Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
27.86
+0.25 (0.91%)
At close: Mar 16, 2026, 4:00 PM EDT
28.10
+0.24 (0.86%)
After-hours: Mar 16, 2026, 7:34 PM EDT

HRMY Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,6112,1601,9661,8343,2852,508
Market Cap Growth
-14.20%9.85%7.24%-44.18%30.96%21.96%
Enterprise Value
1,0051,5281,6621,6593,1512,464
Last Close Price
27.8637.4234.4132.3055.1042.64
PE Ratio
10.2813.8113.7115.1618.5573.52
Forward PE
7.8410.0511.8211.1423.0125.27
PEG Ratio
0.440.390.470.73--
PS Ratio
1.862.492.753.157.508.21
PB Ratio
1.852.482.983.938.1513.45
P/TBV Ratio
1.872.523.024.188.3613.54
P/FCF Ratio
4.636.218.998.3722.7625.53
P/OCF Ratio
4.636.208.958.3622.7425.45
EV/Sales Ratio
1.161.762.332.857.208.07
EV/EBITDA Ratio
4.306.547.737.6721.9523.16
EV/EBIT Ratio
4.827.338.718.6426.2228.15
EV/FCF Ratio
2.894.397.607.5721.8425.08
Debt / Equity Ratio
0.170.170.250.380.471.02
Debt / EBITDA Ratio
0.700.700.830.901.341.81
Debt / FCF Ratio
0.470.470.820.881.331.95
Net Debt / Equity Ratio
-0.70-0.70-0.44-0.34-0.33-0.23
Net Debt / EBITDA Ratio
-2.62-2.62-1.34-0.74-0.92-0.40
Net Debt / FCF Ratio
-1.76-1.76-1.32-0.73-0.91-0.43
Asset Turnover
0.760.760.790.780.790.71
Inventory Turnover
31.6031.6024.9725.1019.1313.45
Quick Ratio
3.463.463.142.614.795.01
Current Ratio
3.603.603.312.755.075.29
Return on Equity (ROE)
20.75%20.75%25.84%29.63%61.58%24.39%
Return on Assets (ROA)
13.55%13.55%15.99%19.21%37.63%18.80%
Return on Invested Capital (ROIC)
47.48%47.48%41.60%48.17%98.22%75.99%
Return on Capital Employed (ROCE)
22.62%22.62%25.93%30.91%24.66%26.04%
Earnings Yield
9.85%7.24%7.29%6.59%5.39%1.36%
FCF Yield
21.59%16.11%11.12%11.95%4.39%3.92%
Buyback Yield / Dilution
-0.47%-0.47%-0.33%5.18%-0.27%-1.57%
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q